Page 8 - Nick Benedetto News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Phathom Pharmaceuticals Announces Proposed Public Offering of 2,250,000 Shares of Common Stock Phathom Pharmaceuticals Announces Proposed Public Offering of 2,250,000 Shares of Common Stock FLORHAM PARK, N.J., Dec. 15, 2020 Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, announced today that it intends to offer and sell, subject to market and other conditions, 2,250,000 shares of its common stock in an underwritten public offering. In addition, Phathom intends to grant the underwriters a 30-day option to purchase up to an additional 337,500 shares of common stock. All of the shares to be sold in the offering are to be sold by Phathom. There can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

New yorkUnited statesTimes squareTodd branningNick benedettoEquity syndicate departmentPhathom pharmaceuticalsGuggenheim securitiesNeedham companyCompany annual report on formExchange commissionPhathom pharmaceuticals incEquity syndicate prospectus departmentCapital markets corpEvercore groupEquity capital markets